Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law BPC 157 Banned: Key Facts on the Latest FDA Decision BPC 157: Experimental Peptide Creates Risk for Athletes In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking Compounded "semaglutide" is not FDA approved semaglutide.com Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives